Clinical Trial Update: Efficacy and Safety of ZT006 in Overweight and Obese Participants [Phase 2]

View source ↗

Summary

This document provides an update on the efficacy and safety findings from a Phase 2 trial of ZT006 in overweight and obese participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• ZT006

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight , Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING